Cytodyn Inc (CYDY)

[Chuckles759]

Whoa there Hoss....

The Phase 3 trial for severe COVID-19 patients has built in an interim analysis to be conducted after 40% (245) of the patients have been enrolled and the last-enrolled patient has completed 28 days of treatment with leronlimab.

https://www.cytodyn.com/newsroom/press-releases/detail/547/cytodyn-receives-clearance-from-brazils-anvisa-to

With the continued onslaught of COVID cases in Brazil, the 245 patient enrollment point shouldn't be too far down the time line. Especially with the growing awareness of how quickly patients recover with no side effects. Then we can add a couple of weeks for Albert Einstein Israelite Hospital to snapshot the data and do the interim analysis. Those numbers will take a couple of days to be looked over by CYDY and formulated into a PR.

But....no...it won't be sometime in 2022. I'm expecting mid-November 2021 at the latest.

Also, Google Trends is noting an increasing and sustained interest in "leronlimab" and "CytoDyn" - worldwide.


Not everyone pays attention to anonymous internet message boards for how to guide their and their loved ones' health and survival.

The word is getting out - and the word is LERONLIMAB.